NAD+ Peptide Purity Testing: How to Evaluate Research Compounds from Suppliers | Palmetto Peptides

NAD+ Peptide Purity Testing: How to Evaluate Research Compounds from Suppliers

Research Notice: This article covers research on NAD+ research peptide and MOTS-C research peptide — available from Palmetto Peptides for laboratory use only.

Research Use Only Disclaimer: All peptides listed on this page are sold exclusively for in vitro and legitimate laboratory research purposes. They are not intended for human consumption, veterinary use, or any clinical application. The information in this article is for scientific and educational reference only and does not constitute medical advice. All research use must comply with applicable federal, state, and institutional regulations. Palmetto Peptides complies fully with all applicable FDA guidelines.

Research Disclaimer: All content on this page is intended strictly for educational and scientific research purposes. NAD+ is sold by Palmetto Peptides exclusively for laboratory use. It is not intended for human or veterinary use, and it is not a drug, supplement, or therapeutic product. Nothing on this page constitutes medical advice.

Part of the NAD+ Research Cluster: This article is a supporting resource within the Palmetto Peptides Complete Guide to the Research Peptide NAD+ — the central reference for NAD+ laboratory research.

When a supplier says NAD+ is 98% pure, what exactly does that mean? The answer depends entirely on how the purity was measured — because not all analytical methods are equally capable of detecting the full range of impurities that might be present in a NAD+ preparation.

For researchers who need reliable, reproducible results, understanding how purity testing works — and what specific methods are appropriate for NAD+ — is not an optional detail. It is the difference between knowing what you are working with and hoping for the best.

This article provides a technical overview of the key analytical methods used to test NAD+ research compound purity, explains what each method can and cannot detect, and offers practical guidance for evaluating the quality documentation provided by suppliers.

Last Updated: April 6, 2026 | Reading Time: Approximately 12 minutes | Author: Palmetto Peptides Research Team

Quick Answer

Part of the NAD+ Research Cluster: This article is a supporting resource within the Palmetto Peptides Complete Guide to the Research Peptide NAD+ — the central reference for NAD+ laboratory research. NAD+ Peptide Purity Testing: How to Evaluate Research Compounds from Suppliers

The Purity Question: What Are We Actually Measuring?

Purity, in analytical chemistry, is defined as the proportion of a sample that is the target compound. A compound described as 98% pure by HPLC means that 98% of the total peak area in the chromatogram is attributed to NAD+, and the remaining 2% is attributed to other compounds — impurities, degradation products, or synthesis byproducts.

This definition has a critical implication: purity is only as good as the analytical method's ability to detect and quantify the impurities present. A method that cannot distinguish NAD+ from a structurally similar impurity will measure artificially high purity by missing the contaminant. This is why method selection matters as much as the purity number itself.

Primary Analytical Methods for NAD+ Purity Testing

HPLC: The Gold Standard for Purity

High-performance liquid chromatography (HPLC) is the most widely used and most appropriate analytical method for quantifying NAD+ purity in research compound preparations.

How it works: A dissolved sample is injected onto a column packed with a stationary phase material. The mobile phase (a liquid, typically an aqueous/organic solvent mixture) carries the sample through the column under high pressure. Different compounds in the sample travel through the column at different rates depending on their affinity for the stationary phase, emerging at different times (called retention times). A detector — typically a UV detector at 260 nm for NAD+ — measures the signal from each compound as it exits the column.

What HPLC can detect for NAD+ preparations:

Nicotinamide

Yes

Distinct retention time from NAD+

NMN

Distinct retention time

ADPR

AMP

NADH

Different UV absorption profile at 340 nm

Residual synthesis solvents

Depends on detector type

PDA or MS coupling improves detection

Reverse-phase HPLC (C18 column) is the most common configuration for nucleotide analysis, though ion-pairing or ion-exchange methods are also used for NAD+ and related compounds. The specific column and mobile phase conditions affect which impurities are resolved and how well. A COA that identifies the HPLC column type and mobile phase conditions provides more transparency than one that simply states "HPLC."

What HPLC cannot do: HPLC separates and quantifies compounds but does not directly confirm molecular identity. A contaminant that co-elutes with NAD+ (same retention time) would be hidden in the NAD+ peak and contribute to an artificially high apparent purity. This is why identity confirmation by mass spectrometry is a necessary complement to HPLC purity data.

Mass Spectrometry: Confirming Molecular Identity

Mass spectrometry (MS) measures the mass-to-charge ratio of ionized molecules. For NAD+ quality testing, it is used primarily for identity confirmation — verifying that the compound in the vial is actually NAD+ and not an impostor with similar chromatographic behavior.

NAD+ (free acid form) has a molecular mass of 663.43 g/mol. In electrospray ionization (ESI) mass spectrometry — the most common mode for biological molecules — NAD+ is typically detected as: - [M+H]+ at m/z 664.1 (positive mode) - [M-H]- at m/z 662.1 (negative mode)

A COA with MS data should report the observed m/z value and confirm it is consistent with the expected NAD+ molecular mass. Significant deviations would indicate a different compound is present.

LC-MS (liquid chromatography combined with mass spectrometry) is particularly powerful because it provides both the chromatographic separation of HPLC and the mass-based identity confirmation of MS simultaneously. LC-MS can detect trace impurities with unique masses even when they co-elute with NAD+, because the mass spectrum distinguishes them from NAD+ itself.

NMR Spectroscopy: Structural Confirmation

Nuclear magnetic resonance (NMR) spectroscopy probes the chemical environment of specific atomic nuclei — typically protons (¹H-NMR) or carbon-13 (¹³C-NMR) — in a molecule, producing a spectrum that is a fingerprint of the compound's chemical structure.

For NAD+ identity testing, ¹H-NMR can confirm the presence of the adenosine and nicotinamide proton environments characteristic of NAD+, verify the oxidized form (NAD+ vs. NADH, which have distinguishable NMR profiles), and identify structural impurities that might not be resolved by HPLC.

NMR is less commonly included in routine research compound COAs (due to the time and cost of NMR analysis) but represents the highest level of structural confirmation available. Its presence in a COA indicates a serious quality commitment from the supplier.

UV-Visible Spectrophotometry: Concentration Estimation, Not Purity Confirmation

Some suppliers report purity based on UV spectrophotometry alone — measuring absorbance at 260 nm and calculating concentration from the known extinction coefficient of NAD+.

The problem: UV absorbance at 260 nm measures all UV-absorbing species in the solution, not just NAD+. Impurities that absorb at similar wavelengths — including NMN, ADPR, AMP, and nicotinamide — will contribute to the measured absorbance. A "purity" value derived solely from UV absorbance is not a true purity measurement; it is a concentration estimate that will overstate NAD+ content if UV-absorbing impurities are present.

UV spectrophotometry has legitimate uses as a quick concentration check but should not be cited as a primary purity method in a COA. Any supplier claiming high purity based solely on UV absorbance should be questioned.

Reading an NAD+ COA: A Step-by-Step Evaluation

Here is how to systematically evaluate a COA provided by an NAD+ supplier:

Step 1: Confirm lot traceability Find the lot number on the COA. Does it match the lot number on your product vial or order confirmation? If the COA has no lot number, or if the numbers do not match, the COA does not document the actual compound you received.

Step 2: Evaluate the purity method Look for the analytical method used to determine purity. The COA should specify: - Method type (HPLC, LC-MS, etc.) - Column and mobile phase conditions, or at minimum the method identifier - Detection wavelength (260 nm for NAD+, or 210 nm for broader detection)

If only "UV spectrophotometry" is listed without HPLC separation, the purity measurement is methodologically inadequate.

Step 3: Verify the identity confirmation Look for mass spectrometry data confirming the molecular mass. The observed m/z should be consistent with NAD+ (MW ~663 Da). If only HPLC purity is given without any identity confirmation, the compound's identity has not been independently verified.

Step 4: Check the testing laboratory Is the testing lab identified? Is it the same entity as the supplier (in-house testing) or an independent third-party? Third-party testing from a named, independent laboratory provides stronger evidence than self-reported data.

Step 5: Verify the testing date When was this lot tested? Is the COA recent, or is it a generic document from years ago that may not reflect the current lot?

Step 6: Confirm research-use-only status The COA and associated product materials should explicitly state that the compound is for research use only and not for human or veterinary use.

In-Laboratory Verification: What Researchers Can Do

Even with a high-quality COA, researchers who want maximum confidence in their compound can perform in-laboratory checks before use:

Enzymatic Activity Verification

A commercial NAD+/NADH quantification assay kit provides a functional test of NAD+ activity. The enzymatic cycling reaction in these kits specifically amplifies the NAD+ signal, allowing quantification of active NAD+ in a sample. Comparing the kit-measured concentration to the expected concentration based on the weighed mass provides a functional confirmation of compound integrity.

UV Absorbance Check

While UV absorbance alone cannot confirm purity, it can detect gross degradation. If the A260 of a freshly prepared solution is dramatically lower than expected based on the extinction coefficient of NAD+ (ε = ~18,000 M⁻¹cm⁻¹ at 260 nm), significant degradation has likely occurred. This is a useful quick check when working with stored stocks.

NADH Contamination Check

NADH absorbs at 340 nm; NAD+ does not. Measuring A340 on a freshly prepared NAD+ solution provides a simple check for NADH contamination. The A340 should be near zero for pure NAD+ preparations. Any significant A340 signal indicates NADH contamination or incomplete oxidation state control during synthesis.

Purity Testing Summary for Different Researcher Needs

Routine cell biology experiments

HPLC ≥98% purity, any identity confirmation

Enzyme kinetics assays

HPLC ≥99% purity, MS identity confirmation

Comparative studies with published data

Match method standards of published work

High-precision quantitative assays

HPLC ≥99% + MS + in-lab enzymatic verification

Palmetto Peptides NAD+ Purity Standards

All NAD+ research compounds sold by Palmetto Peptides are:

Third-party tested by independent analytical laboratories

HPLC purity ≥98% (lot-specific results available on COA)

Identity confirmed by mass spectrometry

Lot-specific COAs available for download with every purchase

View NAD+ Research Compound | Request Certificate of Analysis